Support new, patient-powered brain cancer research

17 Nov 2026
Robyn Leonard

“The launch of Opt Me In is the result of years of work driven by one purpose: making things better for people with brain cancer.”

Robyn Leonard OAM

Help fund patient-powered brain cancer research this Christmas.

Brain Cancer Australia has launched its Christmas Appeal, calling on the community to help raise $150,000 for Opt Me In.

For too long, many Australians diagnosed with brain cancer have experienced a sense of helplessness. Why was life expectancy so short? Why was there so little research being funded? And so few new treatments? Why was it so difficult for patients to find and take part in research studies and trials?

Opt Me In is the new infrastructure that lets Australians with brain cancer easily take part in data-driven trials and research studies. It removes many barriers to patient participation and will help give researchers vital, real-world data in a more cost-effective way than before.

Opt Me In will open up new possibilities for advances in brain cancer research – but only if it is supported by funding.

“The launch of Opt Me In is the result of years of work driven by one purpose: making things better for people with brain cancer,” says Robyn Leonard, Founder and Director of Brain Cancer Australia.

Funds raised through the appeal could support research like the VORA study, the first patient-powered study run through Opt Me In. VORA will look at the long-term impacts of a new brain cancer treatment called vorasidenib.

Daniel Campbell, a husband and father of two who was diagnosed with brain cancer in 2022, will take part in VORA.

For Daniel, knowing research is under way helps ease the distress of living with brain cancer.

“Every small step forward provides immense respite from a deep feeling of vulnerability,” he said

Please donate this Christmas help change outcomes for Australians with brain cancer.

Daniel Campbell and his wife smiling together at an event
Daniel Campbell, pictured with his wife.